Joan Nickerson - Net Worth and Insider Trading

Joan Nickerson Net Worth

The estimated net worth of Joan Nickerson is at least $52,387 dollars as of 2024-11-05. Joan Nickerson is the Chief Administrative Officer of Verve Therapeutics Inc and owns about 8,659 shares of Verve Therapeutics Inc (VERV) stock worth over $52,387. Details can be seen in Joan Nickerson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joan Nickerson has not made any transactions after 2024-04-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joan Nickerson

To

Joan Nickerson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joan Nickerson owns 1 companies in total, including Verve Therapeutics Inc (VERV) .

Click here to see the complete history of Joan Nickerson’s form 4 insider trades.

Insider Ownership Summary of Joan Nickerson

Ticker Comapny Transaction Date Type of Owner
VERV Verve Therapeutics Inc 2024-04-02 Chief Administrative Officer

Joan Nickerson Latest Holdings Summary

Joan Nickerson currently owns a total of 1 stock. Joan Nickerson owns 8,659 shares of Verve Therapeutics Inc (VERV) as of April 2, 2024, with a value of $52,387.

Latest Holdings of Joan Nickerson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VERV Verve Therapeutics Inc 2024-04-02 8,659 6.05 52,387

Holding Weightings of Joan Nickerson


Joan Nickerson Form 4 Trading Tracker

According to the SEC Form 4 filings, Joan Nickerson has made a total of 1 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Verve Therapeutics Inc is the sale of 1,514 shares on April 2, 2024, which brought Joan Nickerson around $12,475.

Insider Trading History of Joan Nickerson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joan Nickerson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joan Nickerson Ownership Network

Ownership Network List of Joan Nickerson

No Data

Ownership Network Relation of Joan Nickerson

Insider Network Chart

Joan Nickerson Owned Company Details

What does Verve Therapeutics Inc do?

Who are the key executives at Verve Therapeutics Inc?

Joan Nickerson is the Chief Administrative Officer of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include See Remarks Andrew D. Ashe , director & 10 percent owner Krishna Yeshwant , and Chief Financial Officer Allison Dorval .

Verve Therapeutics Inc (VERV) Insider Trades Summary

Over the past 18 months, Joan Nickerson made 1 insider transaction in Verve Therapeutics Inc (VERV) with a net sale of 1,514. Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,800,000 shares made by Krishna Yeshwant , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 554 shares made by Allison Dorval .

In summary, during the past 3 months, insiders sold 0 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,068 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,932 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Verve Therapeutics Inc Insider Transactions

No Available Data

Joan Nickerson Mailing Address

Above is the net worth, insider trading, and ownership report for Joan Nickerson. You might contact Joan Nickerson via mailing address: C/o Verve Therapeutics, Inc., 201 Brookline Avenue, Suite 601, Boston Ma 02215.